CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Fundação Pio XII (FP). Hospital do Câncer de Barretos (Institutional affiliation for the last research proposal) Birthplace: Brazil
graduate at Faculdade de medicina from Universidade Estadual Paulista Júlio de Mesquita Filho (1994). Has experience in Medicine, focusing on Surgical Oncology, acting on the following subjects: sarcomas, melanomas and mesenchymal tumors. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
The multidisciplinary auditorium offers all its users the necessary support to perform multiple didactic activities such as classes, seminar presentations, multidisciplinary meetings, and events as workshops, conferences and lectures. It is an important resource for the regular activities of our stricto sensu and lato sensu graduate programs. Envisioned to cater to Pio XII Foundation memb…
Melanoma accounts for more than 90% of skin cancer deaths. BRAF, NRAS and TERT promoter mutations, together, affect more than two thirds of the melanomas. Screening for BRAF mutations in tumor tissue is important for therapeutic decision and prediction of response to target therapy. Monitoring of metastatic disease using this marker necessitates the availability of tumor sample. Liquid bi…
(Only some records are available in English at this moment)
In recent years there is a global effort to characterize the molecular changes associated with the pathogenesis of melanoma. Thus, it was possible to create specific drugs against these changes, which significantly increased the survival of patients with melanoma patients. The TCGA (The Cancer Genome Atlas), the major methylation analysis in this tumor type, included 80% of metastatic sam…
Skin cancer is the most incident cancer of all and is basically divided in non-melanoma and melanoma. Melanoma is the most aggressive type among those described, with a high risk of metastatic dissemination. Its incidence is low in Brazil, but the mortality is considered high. The most frequent clinical sign is the change of a pigment lesion, changing color or its size. Microscopic stagin…
(Only some records are available in English at this moment)
The proposal of the main study is to interrogate the epigenetic role in melanoma initiation and progression. The International Agency for Research on Cancer (IARC) is an intergovernmental agency that is part of the World Health Organization (WHO). Dr Zdenko Herceg is the principal investigator of the Epigenetics Group at IARC. His group has a great expertise in the epigenetic analysis of …
| 6 / 5 | Completed research grants |
| 1 / 1 | Ongoing scholarships in Brazil |
| 10 / 8 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 18 / 15 | All research grants and scholarships |
| Associated processes | |